Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 248

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study

Open access
Elnabawi, Youssef A, Dey, Amit K, Goyal, Aditya, Groenendyk, Jacob W, Chung, Jonathan H, Belur, Agastya D, Rodante, Justin, Harrington, Charlotte L, Teague, Heather L, Baumer, Yvonne, Keel, Andrew, Playford, Martin P, Sandfort, Veit, Chen, Marcus Y, Lockshin, Benjamin, Gelfand, Joel M, Bluemke, David A, Mehta, Nehal N · 2019 · Cardiovascular Research

Abstract

AIMS: The use of biologic therapy has increased over the past decade well beyond primary autoimmune diseases. Indeed, a recent trial using an anti-IL-1beta antibody reduced second myocardial infarction (MI) in those who have had MI. Psoriasis is a chronic inflammatory disease often treated with biologics when severe, is associated with increased risk of MI, in part driven by high-risk coronary plaque phenotypes by coronary computed tomography angiography (CCTA). We hypothesized that we would observe a reduction in inflammatory-driven phenotypes of coronary plaque, including non-calcified coronary plaque burden and lipid-rich necrotic core in those treated with biologic therapy after one-year compared with non-biologic therapy. METHODS AND RESULTS: In a prospective, observational study, 290 participants were recruited from 1 January 2013 through 31 October 2018 with 215 completing one-year follow-up. Of the 238, 121 consecutive participants who were biologic treatment naïve at baseline were included. A blinded reader (blinded to patient demographics, visit and treatment) quantified total coronary plaque burden and plaque subcomponents (calcified and non-calcified) in the three main coronary vessels >2 mm using dedicated software (QAngio, Medis, Netherlands). Psoriasis patients were middle-aged [mean (standard deviation) age, 50.5 (12.1) years], mostly male (n = 70, 58%) with low cardiovascular risk by Framingham score [median (interquartile range, IQR), 3 (1-6)] and had moderate to severe skin disease at baseline [median (IQR) Psoriasis Area Severity Index, PASI, 8.6 (5.3-14.0)]. Biologic therapy was associated with a 6% reduction in non-calcified plaque burden (P = 0.005) reduction in necrotic core (P = 0.03), with no effect on fibrous burden (P = 0.71). Decrease in non-calcified plaque burden in the biologic treated group was significant compared with slow plaque progression in non-biologic treated (Δ, -0.07 mm2 vs. 0.06 mm2; P = 0.02) and associated with biologic treatment beyond adjustment for traditional cardiovascular risk factors (β = 0.20, P = 0.02). CONCLUSION: In this observational study, we demonstrate that biologic therapy in severe psoriasis was associated with favourable modulation of coronary plaque indices by CCTA. These findings highlight the importance of systemic inflammation in coronary artery disease and support the conduct of larger, randomized trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvz009

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 248

Metadata

Authors
Elnabawi, Y. A., Dey, A. K., Goyal, A., Groenendyk, J. W., Chung, J. H., Belur, A. D., Rodante, J., Harrington, C. L., Teague, H. L., Baumer, Y., Keel, A., Playford, M. P., Sandfort, V., Chen, M. Y., Lockshin, B., Gelfand, J. M., Bluemke, D. A., & Mehta, N. N.
Venue
Cardiovascular Research
Published
2019-02-05
Volume
115
Issue
4
Pages
721-728
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W2912436760
Cited by
248
References
5
FWCI
11.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. https://app.cochat.ai/papers/10.1093/cvr/cvz009
The paper
Elnabawi, Y. A., Dey, A. K., Goyal, A., Groenendyk, J. W., Chung, J. H., Belur, A. D., Rodante, J., Harrington, C. L., Teague, H. L., Baumer, Y., Keel, A., Playford, M. P., Sandfort, V., Chen, M. Y., Lockshin, B., Gelfand, J. M., Bluemke, D. A., & Mehta, N. N. (2019). Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovascular Research. https://doi.org/10.1093/cvr/cvz009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.